American Society of Clinical Oncology (ASCO) shared a post on LinkedIn:
“Cancer incidence and mortality are rising in the Global South, and frequent delays in diagnosis often hinder treatment initiation and adversely impact clinical outcomes. Artificial intelligence may be an answer to improving access and ensuring high-quality care in resource-limited settings through AI-driven digital pathology.
In a new editorial for ASCO Daily News, ASCOBT26 faculty members explain how integrating this technology into routine practice can leverage its high-powered analytical capability to help overcome diagnostic and cost constraints. ”
Other articles about American Society of Clinical Oncology on Oncodaily.